Current Heart Failure Reports

, Volume 4, Issue 2, pp 110–116

Tips and tricks on outpatient initiation and uptitration of beta-blockade in heart failure

Article

DOI: 10.1007/s11897-007-0009-2

Cite this article as:
Tsai, S. & Klapholz, M. Curr Heart Fail Rep (2007) 4: 110. doi:10.1007/s11897-007-0009-2
  • 28 Views

Abstract

β-blockade has a therapeutic role across the continuum of patients with heart failure (HF), with a demonstrated mortality benefit in stage II and III HF. Concerns regarding initiation and uptitration linger as patients with resting bradycardia, pulmonary, or vascular disease are often unnecessarily excluded from receiving therapy. We will review the risk data on β-blockade and offer therapeutic strategies to help overcome residual barriers to the initiation and uptitration of this important therapy in patients with HF.

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  1. 1.New Jersey Medical SchoolUniversity of Medicine and Dentistry of New JerseyNewarkUSA